Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal a Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy With Epirubicin Plus Paclitaxel

PLoS ONE - United States
doi 10.1371/journal.pone.0104870
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)


Related search